Strata Critical Medical, Inc.
SRTA
$5.43
-$0.06-1.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 228.58M | 197.14M | 166.74M | 153.51M | 131.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 228.58M | 197.14M | 166.74M | 153.51M | 131.25M |
| Cost of Revenue | 180.39M | 156.02M | 132.27M | 123.14M | 104.75M |
| Gross Profit | 48.19M | 41.13M | 34.47M | 30.36M | 26.50M |
| SG&A Expenses | 53.35M | 51.13M | 52.60M | 54.88M | 42.41M |
| Depreciation & Amortization | 4.09M | 3.01M | 1.67M | 1.67M | 1.67M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 237.42M | 209.75M | 186.46M | 179.57M | 148.16M |
| Operating Income | -8.85M | -12.61M | -19.71M | -26.06M | -16.91M |
| Income Before Tax | -16.05M | -20.07M | -22.11M | -18.08M | -13.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.05 | -20.07 | -22.11 | -18.08 | -13.54 |
| Earnings from Discontinued Operations | 63.05M | 61.41M | 62.50M | -905.00K | -571.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.99M | 41.35M | 40.39M | -18.98M | -26.57M |
| EBIT | -8.85M | -12.61M | -19.71M | -26.06M | -16.91M |
| EBITDA | -583.00K | -5.71M | -14.75M | -20.24M | -11.30M |
| EPS Basic | 0.57 | 0.50 | 0.48 | -0.24 | -0.34 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.12 | -0.17 | -0.09 |
| EPS Diluted | 0.57 | 0.50 | 0.47 | -0.24 | -0.34 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.12 | -0.17 | -0.09 |
| Average Basic Shares Outstanding | 333.08M | 327.65M | 321.50M | 317.09M | 313.18M |
| Average Diluted Shares Outstanding | 337.93M | 327.65M | 321.50M | 317.09M | 313.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |